Navigation Links
Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
Date:4/1/2008

reatic cancer with a novel mechanism of action. BZL101 targets cancer cells while leaving normal cells healthy and intact. Normal cells depend primarily on the citric acid cycle (>85%) and very little on glycolysis (<7%) for energy production. In contrast, cancer cells depend largely on glycolysis (>85%) for energy production. BZL101 leads to energy collapse in cancer cells by inhibiting glycolysis. This leads to DNA damage and cell death in cancer cells while normal cells remain unharmed.

BZL101 has completed early stage clinical testing conducted at the University of California, San Francisco and the Cancer Research Network in Plantation, Florida. Data from the Phase 1 trial of BZL101 indicate that BZL101 has a favorable tolerability profile and demonstrates encouraging clinical activity in a heavily pretreated population. BZL101 is currently undergoing Phase 1/2 clinical testing for late stage metastatic breast cancer. Visit http://www.bzl101.com to find out more about BZL101.

Bionovo, Inc.

Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.bionovo.com.

Forward Looking Statements

This release contains certain for
'/>"/>

SOURCE Bionovo Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
2. Kingfisher Announces FDA 510(k) Clearance of Breakthrough KFH Energy for Chronic Pain Sufferers
3. Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting
4. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
5. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
6. Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
7. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
8. Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
9. Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 19, 2014  SCILEX Pharmaceuticals, Inc., a company engaged ... for the treatment of pain, announced that it had formed ... Jeff Gudin , Dr. Charles Argoff , ... Vought . SCILEX Chief Executive Officer ... board would greatly assist in the development and commercialization ...
(Date:8/19/2014)... Colo. , Aug. 19, 2014 ... Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE), ... rd Annual Meeting of the American Academy ... Acute Care Surgery in Philadelphia, Pennsylvania ... 2014.  The presentation will report results from a ...
(Date:8/19/2014)... 2014 ,Weight Loss- Market Analysis, ... report provides comprehensive insights about phase III pipeline drugs ... of the report is to establish the understanding for ... across the different countries and regions. While the leading ... also provides details on the drug master filings across ...
Breaking Medicine Technology:SCILEX Pharmaceuticals Announces Scientific Advisory Board 2SCILEX Pharmaceuticals Announces Scientific Advisory Board 3SCILEX Pharmaceuticals Announces Scientific Advisory Board 4Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 2Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 3Weight Loss Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 2Weight Loss Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 3Weight Loss Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 4
(Date:8/20/2014)... August 20, 2014 Blaine Labs®, ... innovative RevitaDERM® Psoriasis Treatment to ease ... with psoriasis. This all-in-one product was created to ... Psoriasis Treatment is powered by coal tar and ... with this effective ingredient. , RevitaDERM® Psoriasis ...
(Date:8/20/2014)... BOSTON As people grow older, they often have ... awaken too early in the morning. In individuals with ... tends to be especially pronounced, often leading to nighttime ... researchers at Beth Israel Deaconess Medical Center (BIDMC) and ... why sleep becomes more fragmented with age. Reported online ...
(Date:8/20/2014)... Angeles, CA (PRWEB) August 20, 2014 GBK, ... honor the 2014 Emmy Award Nominees and Presenters at the ... on August 22nd and 23rd in Beverly Hills from 11am ... gifts, refreshments and music by DJ Morgan Hildebrand. , As ... fundraising and will feature several charities at the lounge. GO ...
(Date:8/20/2014)... Kowa Optimed returns after a short ... the new SL-17 portable slit lamp. , The SL-17 ... source controlled by an illuminated thumb wheel for easy ... commercially available AAA rechargeable and dry cell batteries, which ... batteries designed specifically for the device. The new Sl-17 ...
(Date:8/20/2014)... Over 31 million Americans suffer from low back ... pain is the single leading cause of disability worldwide, and ... Americans spend at least $50 billion each year trying to ... pain are not due to organic conditions such as arthritis; ... a busy accountant, had little time for physical activity or ...
Breaking Medicine News(10 mins):Health News:RevitaDERM® Psoriasis Treatment Now Available At Over 7,600 CVS/pharmacies 2Health News:Research helps explain why elderly have trouble sleeping 2Health News:Research helps explain why elderly have trouble sleeping 3Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 2Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 3Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 4Health News:Kowa Optimed (Booth MS13043) to Debut New Portable Slit Lamp at 2014 Vision Expo West in Las Vegas, Nevada 2Health News:Physical Therapists Learn to Relieve Low Back Pain 2
... ... Local Academy Offers Training & Education , ... (PRWEB) February 5, 2010 -- During these difficult economic times, we are ... the job to apply for just isn’t there. There is one piece of advice that ...
... , NEW YORK ... (HSS), a world leader in orthopedics and rheumatology, today announced ... launched campaign, "Moving is the Best Medicine," to raise awareness ... , "Like the Arthritis Foundation, we are focusing our extensive ...
... TSX:HAE , MONTREAL , Feb. 5 /PRNewswire-FirstCall/ - ... extension until March 22, 2010 of the delay within ... to make a proposal to its creditors it filed on ... Canada ). This extension is intended to allow Haemacure to complete ...
... , , BEIJING, CHINA , Feb. 5 /PRNewswire-FirstCall/ ... a certain previously released news announcements namely January 7 2009, ... 12,2010 , and January 22, 2010 . , These are significant ... are now starting to crystallize and are beginning to transform HTDS from ...
... in training and bioethicists at Johns Hopkins have created ... quickly assess a patient,s decision-making capacity in an emergency. ... to use it, will be published in the February ... and Communicate, Understand, Reason, Value, Emergency and Surrogate. Doctors ...
... to misuse prescribed drugs, suffer flareups , FRIDAY, ... use herbal remedies experience increased symptoms and poorer quality ... 326 asthma patients for 33 months. Of those patients, ... prescribed inhaled corticosteroids (ICS) less often than other patients. ...
Cached Medicine News:Health News:Addiction Industry Thrives Amidst Economic Climate, Seeks Certified Candidates 2Health News:HSS Supports Arthritis Foundation Focus on Raising National Awareness of Osteoarthritis 2Health News:HSS Supports Arthritis Foundation Focus on Raising National Awareness of Osteoarthritis 3Health News:HSS Supports Arthritis Foundation Focus on Raising National Awareness of Osteoarthritis 4Health News:Hard to Treat Diseases (HTDS) Update On Various Business Developments Evaluations and Proposals 2Health News:Hard to Treat Diseases (HTDS) Update On Various Business Developments Evaluations and Proposals 3Health News:Hard to Treat Diseases (HTDS) Update On Various Business Developments Evaluations and Proposals 4Health News:Hard to Treat Diseases (HTDS) Update On Various Business Developments Evaluations and Proposals 5Health News:Bioethics memory aid can help assess patient decision-making capacity in medical emergencies 2Health News:Bioethics memory aid can help assess patient decision-making capacity in medical emergencies 3Health News:Herbals Not the Answer for Asthma, Study Shows 2
... ECG Systems offer clinical features to meet ... functionality for paperless storage. Flexible, affordable, and ... PCE Exercise ECG software turns any computer ... with its ability to connect with leading ...
... CardioDirect12-S is the stress testing system from ... turn-key system including treadmill or bicycle ergometer, ... BP option. It uses the same CardioDirect ... resting ECG. ,The system is ...
... Burdick ExTOL systems feature your choice ... multi-channel electrocardiographs, an easy-to-operate monitor and ... ExTOL exercise stress testing systems also ... measurement point, pre-programmed or custom protocols, ...
The Urchin heart positioner provides excellent access to target coronaries while minimizing hemodynamic instability...
Medicine Products: